Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data-Reference-Cited by-同舟云学术

Identification of copy number alterations in colon cancer from analysis of amplicon-based next generation sequencing data

Published:2018-04-17 Issue:29 Volume:9 Page:20409-20425
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Oliveira Duarte Mendes¹,Santamaria Gianluca¹,Laudanna Carmelo¹,Migliozzi Simona¹,Zoppoli Pietro¹,Quist Michael²,Grasso Catie³,Mignogna Chiara⁴,Elia Laura⁵,Faniello Maria Concetta¹,Marinaro Cinzia¹,Sacco Rosario⁵,Corcione Francesco⁶,Viglietto Giuseppe¹,Malanga Donatella¹,Rizzuto Antonia⁵

Affiliation:

1. Dipartimento di Medicina Sperimentale e Clinica, Università Magna Graecia, Catanzaro, Italy

2. Fred Hutchinson Cancer Research Center, Seattle, WA, USA

3. University of California Los Angeles (UCLA), Los Angeles, CA, USA

4. Dipartimento di Scienze della Salute, Università Magna Graecia, Catanzaro, Italy

5. Dipartimento di Scienze Mediche e Chirurgiche, Università Magna Graecia, Catanzaro, Italy

6. UOC Chirurgia Generale, Azienda Ospedaliera dei Colli, Napoli, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics prognostic signatures of IPO11 mRNA expression and clinical outcomes in colorectal cancer using bioinformatics approaches;Health Information Science and Systems;2023-11-27

2. Construction and validation of a prognostic model for gastrointestinal stromal tumors based on copy number alterations and clinicopathological characteristics;Frontiers in Oncology;2022-12-21

3. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study;The Lancet Digital Health;2022-11

4. Colorectal cancer concurrent gene signature based on coherent patterns between genomic and transcriptional alterations;BMC Cancer;2022-05-30

5. Copy Number Alterations as Novel Biomarkers and Therapeutic Targets in Colorectal Cancer;Cancers;2022-04-29